MA24421A1 - NEW THERAPEUTIC APPLICATION OF PYRROLE DERIVATIVES. - Google Patents

NEW THERAPEUTIC APPLICATION OF PYRROLE DERIVATIVES.

Info

Publication number
MA24421A1
MA24421A1 MA24895A MA24895A MA24421A1 MA 24421 A1 MA24421 A1 MA 24421A1 MA 24895 A MA24895 A MA 24895A MA 24895 A MA24895 A MA 24895A MA 24421 A1 MA24421 A1 MA 24421A1
Authority
MA
Morocco
Prior art keywords
new therapeutic
therapeutic application
pyrrole derivatives
pyrrole
derivatives
Prior art date
Application number
MA24895A
Other languages
French (fr)
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of MA24421A1 publication Critical patent/MA24421A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA24895A 1996-12-12 1997-12-10 NEW THERAPEUTIC APPLICATION OF PYRROLE DERIVATIVES. MA24421A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9615287A FR2757059B1 (en) 1996-12-12 1996-12-12 NEW THERAPEUTIC APPLICATION OF PYRROLE DERIVATIVES

Publications (1)

Publication Number Publication Date
MA24421A1 true MA24421A1 (en) 1998-07-01

Family

ID=9498603

Family Applications (1)

Application Number Title Priority Date Filing Date
MA24895A MA24421A1 (en) 1996-12-12 1997-12-10 NEW THERAPEUTIC APPLICATION OF PYRROLE DERIVATIVES.

Country Status (6)

Country Link
AU (1) AU5487298A (en)
FR (1) FR2757059B1 (en)
MA (1) MA24421A1 (en)
TN (1) TNSN97203A1 (en)
WO (1) WO1998025612A1 (en)
ZA (1) ZA9711168B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20020506A1 (en) 2000-08-22 2002-07-09 Glaxo Group Ltd PIRAZOLE DERIVATIVES FUSED AS PROTEIN KINASE INHIBITORS
JP2004515550A (en) 2000-12-15 2004-05-27 グラクソ グループ リミテッド Therapeutic compounds
ATE301653T1 (en) 2000-12-15 2005-08-15 Glaxo Group Ltd PYRAZOLOPYRIDINES
WO2002072581A2 (en) 2001-03-08 2002-09-19 Smithkline Beecham Corporation Pyrazolopyriadine derivatives
WO2002078700A1 (en) 2001-03-30 2002-10-10 Smithkline Beecham Corporation Pyralopyridines, process for their preparation and use as therapteutic compounds
ES2266487T3 (en) 2001-04-10 2007-03-01 Smithkline Beecham Corporation ANTIVIRAL PIRAZOLOPIRINE COMPOUNDS.
ATE296826T1 (en) 2001-04-27 2005-06-15 Smithkline Beecham Corp PYRAZOLO(1,5)PYRIDINE DERIVATIVES
ATE337316T1 (en) * 2001-06-21 2006-09-15 Smithkline Beecham Corp IMIDAZO 1,2-AÖPYRIDINE DERIVATIVES FOR THE PROPHYLAXIS AND TREATMENT OF HERPES INFECTIONS
EP1432712B1 (en) 2001-10-05 2006-05-17 SmithKline Beecham Corporation Imidazo-pyridine derivatives for use in the treatment of herpes viral infection
JP2005516916A (en) * 2001-12-11 2005-06-09 スミスクライン ビーチャム コーポレーション Pyrazolo-pyridine derivatives as anti-herpes drugs
JP2006504728A (en) 2002-10-03 2006-02-09 スミスクライン ビーチャム コーポレーション Pyrazolopyridine derivative therapeutic compounds
GB0816759D0 (en) * 2008-09-12 2008-10-22 Selcia Ltd Compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2557111B1 (en) * 1983-12-21 1986-04-11 Rhone Poulenc Sante NOVEL ORTHO-CONDENSES OF PYRROLE, THEIR PREPARATION AND THE MEDICINAL PRODUCTS CONTAINING THEM
DE4129779A1 (en) * 1991-09-07 1993-03-11 Boehringer Mannheim Gmbh NEW TRICYCLIC THIAZOLE AND OXAZOLE DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING THEM

Also Published As

Publication number Publication date
WO1998025612A1 (en) 1998-06-18
ZA9711168B (en) 1998-06-15
TNSN97203A1 (en) 2005-03-15
AU5487298A (en) 1998-07-03
FR2757059B1 (en) 1999-01-29
FR2757059A1 (en) 1998-06-19

Similar Documents

Publication Publication Date Title
EE9800227A (en) Lactone derivatives of 17β-carboxy, carbothio- and amidandrostanes
BR9507179A (en) Derivatives of 3-aryl-4-hydroxy-delta3-dihydrothiophene
PT833828E (en) RAPAMICINE DERIVATIVES
BR9612201A (en) Tyrosine derivatives
DE69522717D1 (en) CHINAZOLE DERIVATIVES
DE69611361D1 (en) CHINAZOLIN DERIVATIVES
DE69610698D1 (en) CHINAZOLIN DERIVATIVES
MA23815A1 (en) N- (3-BENZOFURANYL) -URAE DERIVATIVES
PT907364E (en) PHARMACEUTICAL COMPOSITION OF SUSTAINED LIBERTACAO
BR9611834A (en) Oxymethoxy-3-aryl-pyrone derivatives
ATE199150T1 (en) DIPHENYLMETHYLENEPIPERIDINE DERIVATIVES
PT921125E (en) DERIVATIVES OF 1,38-TRIAZA-ESPIRO 4,5 DECAN-4-ONA
MA24421A1 (en) NEW THERAPEUTIC APPLICATION OF PYRROLE DERIVATIVES.
DE69601527D1 (en) Pyrrolylbenzimidazole derivatives
ATA100695A (en) PROTHROMINE DERIVATIVES
PT856007E (en) CYLOPEPTIDES DERIVATIVES
FR2727680B1 (en) NEW 5-PYRROLYL-6-HALOGENO-2- PYRIDYLMETHYLSUFINYLBENZIMIDAZOLE DERIVATIVES
BR9610597A (en) Diarrylalkenylamine derivatives
DE69627830D1 (en) -Pyrazole DERIVATIVES
BR9607046A (en) Derivatives of 3-pyrrolidiliden-2-one-cephalosporins
BR9607396A (en) Isoxazole derivatives
DE59607054D1 (en) 4-amino-benzoylguanidine derivatives
ATE177102T1 (en) CHROMEDER DERIVATIVES
BR9609723A (en) Derivatives of tricetone
FR2735476B1 (en) NEW APPLICATION OF PYRROLE DERIVATIVES